Moderate-to-severe atopic dermatitis in different age groups treated with dupilumab in China. Song X, Liu B, Luan T, Liao S, et al. Allergy 2023 Jan 27. doi: 10.1111/all.15660.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Song X, Liu B, Luan T, Liao S, et al. Moderate-to-severe atopic dermatitis in different age groups treated with dupilumab in China. Allergy 2023 Jan 27. doi: 10.1111/all.15660.
PMID: 36708064